Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$17M
1 round on record
Latest round
$17M
Series A · Aug 2018 · 8 yr ago
Backers
1
Qiming Venture Partners
The money's age
Long since its last round
97 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 6, 2018
Raised a round Series A $17M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Aug 2018 | $17M | — | markets.businessinsider.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Qiming Venture Partners Similar startupsby what they do, their industry and backers
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene modulation therapy utilizing…
Medicine is our platform. Accessibility is our cure.
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…
ACEA Therapeutics is a clinical stage pharmaceutical company with a diverse product portfolio to address unmet medical needs in cancer…
TECHNOLOGY M20 Seq Single-Cell Transcriptome M20 Spatial Spatial Transcriptome PRODUCTS Single-Cell Transcriptome for FFPE Samples…
Overview
Cell and Gene Therapy. Cure Genetics Committed to the development of gene and cell therapy for oncology and genetic diseases Cure Genetics, is a clinical-stage company dedicated to developing cell and gene therapies for solid tumors and genetic diseases.
Financials
Total raised
$17M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2018 | $17M | Details |